DB
CDLX icon

Danske Bank’s Cardlytics CDLX Stock Holding History

Danske Bank’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Buy
+2
New +$15 ﹤0.01% 1068

Other funds holding CDLX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Danske Bank's CDLX Position: Q2 2026 in Review

Danske Bank opened a new position in Cardlytics (CDLX) in Q2 2026: 2 shares worth $9. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings.

26 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Danske Bank held 2 shares of Cardlytics worth $9 as of Q2 2026.
  • Cardlytics was a new Danske Bank position in Q2 2026.
  • Cardlytics made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1068 holding.
  • 26 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.